These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19149858)

  • 1. International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors.
    Mannucci PM; Palhares de Miranda PA
    Haemophilia; 2009 Jan; 15(1):345-7. PubMed ID: 19149858
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
    Blatny J; Kohlerova S; Zapletal O; Fiamoli V; Penka M; Smith O
    Haemophilia; 2008 Sep; 14(5):1140-2. PubMed ID: 18540894
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.
    Roberts HR
    Vox Sang; 1999; 77 Suppl 1():38-41. PubMed ID: 10529686
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait.
    Kanyike FB; Abdul-Salam SA; Prakash B; Sharhan A; Wahib N; Youssef AH
    Haemophilia; 1999 Jul; 5(4):273-5. PubMed ID: 10469183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIIa in an infant with haemophilia A and inhibitors.
    Tengborn L; Kjellman B; Elfstrand PO; Bågenholm T
    Acta Paediatr; 1992; 81(6-7):566-7. PubMed ID: 1392377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA.
    Miranda GG; Rodgers GM
    Haemophilia; 2009 Jan; 15(1):383-5. PubMed ID: 18759746
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective prophylaxis with daily recombinant factor VIIa (rFVIIa-Novoseven) in a child with high titre inhibitors and a target joint.
    Saxon BR; Shanks D; Jory CB; Williams V
    Thromb Haemost; 2001 Oct; 86(4):1126-7. PubMed ID: 11686341
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa.
    Salaj P; Gurlich R; Svorcová V; Marková M; Cetkovský P
    Haemophilia; 2009 Jan; 15(1):380-2. PubMed ID: 18976250
    [No Abstract]   [Full Text] [Related]  

  • 9. On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
    Tarantino M; Aledort L
    Transfusion; 2001 Dec; 41(12):1628-9. PubMed ID: 11778084
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations.
    Jiménez-Yuste V; Alvarez MT; Martín-Salces M; Quintana M; Rodriguez-Merchan C; Lopez-Cabarcos C; Velasco F; Hernández-Navarro F
    Haemophilia; 2009 Jan; 15(1):203-9. PubMed ID: 19149850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
    Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
    Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa.
    Pasa S; Altintas A; Cil T; Danis R; Subasi M; Ayyildiz O; Muftuoglu E
    Haemophilia; 2008 Jul; 14(4):863-5. PubMed ID: 18445012
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
    Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic alternative for haemophiliacs with inhibitors.
    Schulman S
    Acta Paediatr; 1992; 81(6-7):564-5. PubMed ID: 1392376
    [No Abstract]   [Full Text] [Related]  

  • 15. Some recent developments regarding arthropathy and inhibitors in haemophilia.
    Rodriguez-Merchan EC
    Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
    Baudo F; de Cataldo F; Gaidano G;
    Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.
    Leblebisatan G; Sasmaz I; Antmen B; Kilinc Y; Sizmaz S; Yagmur M
    Haemophilia; 2006 Mar; 12(2):187-9. PubMed ID: 16476096
    [No Abstract]   [Full Text] [Related]  

  • 18. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
    Chuansumrit A; Sri-Udomporn N; Srimuninnimit V; Juntarukha R
    Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of different doses of recombinant activated factor VII in the treatment of haemophilia children with inhibitor.
    Chuansumrit A; Sirachainan N; Pakakasama S; Suebsangad A; Chotsuppakarn S; Wongwerawattanakoon P
    Haemophilia; 2008 Sep; 14(5):1143-4. PubMed ID: 18624705
    [No Abstract]   [Full Text] [Related]  

  • 20. Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
    Oldenburg J; Mahlangu JN; Kim B; Schmitt C; Callaghan MU; Young G; Santagostino E; Kruse-Jarres R; Negrier C; Kessler C; Valente N; Asikanius E; Levy GG; Windyga J; Shima M
    N Engl J Med; 2017 Aug; 377(9):809-818. PubMed ID: 28691557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.